Alnylam to Webcast Presentations at Upcoming June Investor Conferences
May 30,2019
-
Jefferies 2019 Global Healthcare Conference on
Friday, June 7, 2019 at10:30 am ET inNew York City Goldman Sachs 40th AnnualGlobal Healthcare Conference on Wednesday, June 12, 2019 at2:40 pm PT (5:40 pm ET ) at theTerranea Resort inRancho Palos Verdes, California
A live audio webcast of each presentation will be available on the Investors section of the Company’s website, www.alnylam.com. A replay will be available on the Alnylam website within 48 hours after each event.
About
Alnylam (Nasdaq: ALNY) is leading the translation of RNA interference
(RNAi) into a new class of innovative medicines with the potential to
transform the lives of people afflicted with rare genetic,
cardio-metabolic, hepatic infectious, and central nervous system/ocular
diseases. Based on Nobel Prize-winning science, RNAi therapeutics
represent a powerful, clinically validated approach for the treatment of
diseases with high unmet need. ONPATTRO® (patisiran) is the
first-ever RNAi therapeutic approved by the U.S.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190530005644/en/
Source:
Alnylam Pharmaceuticals, Inc.
Christine Regan Lindenboom
(Investors
and Media)
617-682-4340
Josh Brodsky
(Investors)
617-551-8276